Literature DB >> 34214493

Uncoupling of IL-6 signaling and LC3-associated phagocytosis drives immunoparalysis during sepsis.

Tonia Akoumianaki1, Katerina Vaporidi2, Eleni Diamantaki2, Frédéric Pène3, Remi Beau4, Mark S Gresnigt5, Marina Gkountzinopulou1, Maria Venichaki6, Elias Drakos7, Jamel El-Benna8, George Samonis1, Kieu T T Le9, Vinod Kumar9, Dimitrios Georgopoulos1, Frank L van de Veerdonk10, Mihai G Netea11, Jean-Paul Latge12, Georgios Chamilos13.   

Abstract

Immune deactivation of phagocytes is a central event in the pathogenesis of sepsis. Herein, we identify a master regulatory role of IL-6 signaling on LC3-associated phagocytosis (LAP) and reveal that uncoupling of these two processes during sepsis induces immunoparalysis in monocytes/macrophages. In particular, we demonstrate that activation of LAP by the human fungal pathogen Aspergillus fumigatus depends on ERK1/2-mediated phosphorylation of p47phox subunit of NADPH oxidase. Physiologically, autocrine IL-6/JAK2/Ninein axis orchestrates microtubule organization and dynamics regulating ERK recruitment to the phagosome and LC3+ phagosome (LAPosome) formation. In sepsis, loss of IL-6 signaling specifically abrogates microtubule-mediated trafficking of ERK, leading to defective activation of LAP and impaired killing of bacterial and fungal pathogens by monocytes/macrophages, which can be selectively restored by IL-6 supplementation. Our work uncovers a molecular pathway linking IL-6 signaling with LAP and provides insight into the mechanisms underlying immunoparalysis in sepsis.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aspergillus fumigatus; IL-6; JAK; LAP; LC3-associated phagocytosis; NADPH oxidase; extracellular-signal-kinase regulated (ERK); microtubules; phagosome; sepsis; sepsis immunoparalysis

Mesh:

Substances:

Year:  2021        PMID: 34214493     DOI: 10.1016/j.chom.2021.06.002

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  5 in total

Review 1.  Targeting immunometabolism in host-directed therapies to fungal disease.

Authors:  Samuel M Gonçalves; Anaísa V Ferreira; Cristina Cunha; Agostinho Carvalho
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

2.  DJ-1 binds to Rubicon to Impair LC-3 Associated Phagocytosis.

Authors:  Sahil Gupta; Hajera Amatullah; James N Tsoporis; Kuiru Wei; Ana Paula Teixeira Monteiro; Amin M Ektesabi; Amir K Varkouhi; Chirag M Vaswani; Amanda Formosa; Alexandre T Fabro; Sri Nagarjun Batchu; Chris Fjell; James A Russell; Keith R Walley; Andrew Advani; Thomas G Parker; John C Marshall; Patricia R M Rocco; Gregory D Fairn; Tak Wah Mak; Claudia C Dos Santos
Journal:  Cell Death Differ       Date:  2022-05-31       Impact factor: 12.067

Review 3.  COVID-19-associated fungal infections.

Authors:  Martin Hoenigl; Danila Seidel; Rosanne Sprute; Cristina Cunha; Matteo Oliverio; Gustavo H Goldman; Ashraf S Ibrahim; Agostinho Carvalho
Journal:  Nat Microbiol       Date:  2022-08-02       Impact factor: 30.964

Review 4.  LAPped in Proof: LC3-Associated Phagocytosis and the Arms Race Against Bacterial Pathogens.

Authors:  Bart J M Grijmans; Sander B van der Kooij; Monica Varela; Annemarie H Meijer
Journal:  Front Cell Infect Microbiol       Date:  2022-01-03       Impact factor: 5.293

Review 5.  A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA).

Authors:  Simon Feys; Maria Panagiota Almyroudi; Reinout Braspenning; Katrien Lagrou; Isabel Spriet; George Dimopoulos; Joost Wauters
Journal:  J Fungi (Basel)       Date:  2021-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.